Post covid syndrome and rheumatic diseases: focus on rheumatoid arthritis (own data)
ES Aronova, BS Belov, GI Gridneva - Meditsinskiy Sovet, 2022 - pesquisa.bvsalud.org
Introduction. In modern reality postcovid syndrome (PCS) is characterized by clinical
heterogeneity and multi-organ involvement, often presenting a differential diagnostic and …
heterogeneity and multi-organ involvement, often presenting a differential diagnostic and …
Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment
GI Gridneva, DE Karateev, EL Luchikhina… - Klinicheskaia …, 2014 - europepmc.org
Aim To study the influence of pharmaceutical form of methotrexate on the acute-phase
response in rheumatoid arthritis. Materials and methods The study included 32 patients (24 …
response in rheumatoid arthritis. Materials and methods The study included 32 patients (24 …
Current issues in the management of patients with HIV infection and rheumatic diseases
GI Gridneva, BS Belov - Modern Rheumatology Journal, 2021 - mrj.ima-press.net
According to experts, the human immunodeficiency virus (HIV) epidemic has a steady
downward trend, but the attention of the medical community to this problem is not waning …
downward trend, but the attention of the medical community to this problem is not waning …
[HTML][HTML] The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study
DE Karateev, EL Luchikhina, GI Gridneva… - Almanac of Clinical …, 2019 - almclinmed.ru
Background: Methotrexate is the main synthetic disease-modifying antirheumatic drug for
the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other …
the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other …
AB0495 Subcutaneous methotrexate safety in RA patients (REMARCA trial materials)
GI Gridneva, Y Muraviev, D Karateev, E Luchikhina - 2015 - ard.bmj.com
Background Methotrexate (MT)–is one of most preferable disease modifying anti-rheumatic
drugs (DMARDs) in rheumatoid arthritis (RA) patients. Objectives Aim–prospective study of …
drugs (DMARDs) in rheumatoid arthritis (RA) patients. Objectives Aim–prospective study of …
AB0387 Efficacy of 12-month therapy with methotrexate solution for subcutaneous injection (SC MTX) in patients with early Ra with different body mass index (BMI)
GI Gridneva, Y Muraviev - 2016 - ard.bmj.com
Background The levels of inflammation markers, specifically C-reactive protein (CRP), are
known to be elevated in patients with excessive body weight. Objectives To evaluate the …
known to be elevated in patients with excessive body weight. Objectives To evaluate the …
Quantitative Determination of Methotrexate, 7-Hydroxymethotrexate, and Methotrexate Polyglutamates in Human Erythrocytes by High-Performance Liquid …
NV Baymeeva, GI Gridneva, IA Tyurin… - Pharmaceutical …, 2022 - Springer
Methotrexate is the drug of choice for the treatment of rheumatoid arthritis. However, some
patients have no or an insufficient effect if the treatment protocol is followed. Therefore, a …
patients have no or an insufficient effect if the treatment protocol is followed. Therefore, a …
[HTML][HTML] Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
GI Gridneva, YV Muravyev, NV Baimeeva… - Modern …, 2020 - mrj.ima-press.net
Objective: to assess the time course of changes in the concentration of methotrexate (MTX)
and its main metabolites in the red blood cells (RBC) and mononuclear cells (MNC) of …
and its main metabolites in the red blood cells (RBC) and mononuclear cells (MNC) of …
[HTML][HTML] Dynamics of T-and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
…, TV Popkova, AP Aleksankin, GI Gridneva… - Modern …, 2022 - mrj.ima-press.net
Objective: assessment of the dynamics of T-and B-lymphocytes subpopulations in
rheumatoid arthritis (RA) during therapy with synthetic disease-modifying antirheumatic …
rheumatoid arthritis (RA) during therapy with synthetic disease-modifying antirheumatic …
Chronic viral hepatitis B and rheumatic diseases: Modern view on problem
GI Gridneva, BS Belov, ES Aronova - Medical alphabet, 2022 - med-alphabet.com
Infection caused by hepatitis B virus (HBV) is one of the most common hemocontact
infections. The special life cycle of the hepatitis B virus, the course of infection, often hidden …
infections. The special life cycle of the hepatitis B virus, the course of infection, often hidden …